Acne in childhood: An update

Pediatric Annals

Volumn 42, Issue 10, 2013, Pages 418-427

  Kim, Wendy ^a   Mancini, Anthony J ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ADAPALENE PLUS BENZOYL PEROXIDE; ANTIBIOTIC AGENT; BENZAMYCIN; BENZOYL PEROXIDE; BENZOYL PEROXIDE PLUS CLINDAMYCIN; CEFALEXIN; CHLORTETRACYCLINE; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE PLUS RETINOIC ACID; COTRIMOXAZOLE; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; KETOCONAZOLE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; PRASTERONE; REACTIVE OXYGEN METABOLITE; RETIN A MICRO; RETINOIC ACID; RETINOID; SALICYLIC ACID; SPIRONOLACTONE; SULFACETAMIDE; TAZAROTENE; TESTOSTERONE; TETRACYCLINE; UNCLASSIFIED DRUG;

ACNE; ANTIBIOTIC RESISTANCE; BODY DYSMORPHIC DISORDER; BONE MARROW SUPPRESSION; BRAIN PSEUDOTUMOR; CHILD; COMEDO; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE RESISTANCE; DISEASE SEVERITY; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; ENTERITIS; ESOPHAGITIS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEPATITIS; HUMAN; HYPERPIGMENTATION; INFLAMMATION; INFLAMMATORY DISEASE; KIDNEY FAILURE; LIVER DYSFUNCTION; LIVER FAILURE; LUPUS LIKE SYNDROME; NODULOCYSTIC ACNE; NOTE; PHOTOSENSITIVITY; PNEUMONIA; PREVALENCE; PSORIASIS; PUBLICATION; PUSTULE; QT PROLONGATION; QUALITY OF LIFE; RATING SCALE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOOTH DISCOLORATION; VAGINA CANDIDIASIS; VESTIBULAR DISORDER;

ACNE VULGARIS; CHILD; HUMANS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84885972907     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20130924-13     Document Type: Note

References (37)

1. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-485.
2. Friedlander SF, Eichenfield LF, Fowler RF, Fried RG, Levy ML, Webster GF. Acne epidemiology and pathophysiology. Semin Cutan Med Surg. 2010;29(2 Suppl 1):2-4.
3. Yentzer BA, Hick J, Reese EL, Uhas A, Feldman SR, Balkrishnan R. Acne vulgaris in the United States: a descriptive epidemiology. Cutis. 2010;86(2):94-99.
4. Mancini AJ, Baldwin HE, Eichenfield LF, Friedlander SF, Yan AC. Acne life cycle: the spectrum of pediatric disease. Semin Cutan Med Surg. 2011;30(3 Suppl):S2-S5.
5. Williams HC, Dellevealle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361-372.
6. Do TT, Zarkhin S, Orringer JS, et al. Computer assisted alignment and tracking of acne lesions indicate that most inflammatory lesions arise from comedones and de novo. J Am Acad Dermatol. 2008;58(4):603-608.
7. Bowe WP, Leyden JJ, Crerand CE, Sarwer DB, Margolis DJ. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol. 2007;57(2):222-230.
8. Pawin H, Chivot M, Beylot C, et al. Living with acne: a study of adolescents'personal experiences. Dermatology. 2007;215(4):308-314.
9. Conrado LA, Hounie AG, Diniz JB, et al. Body dysmorphic disorder among dermatologic patients: prevalence and clinical features. J Am Acad Dermatol. 2010;63(2):435-443.
10. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137(2):246-250.
11. Gupta MA, Gupta AK. Depression and suicidal ideation in patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846-850.
12. Eichenfield LF, Mancini AJ. PedAcne Resource Guide: A Comprehensive Overview of Pediatric Acne & Companion to the Online Self-Assessment Exam. New York, NY: Education Testing & Assessment Systems; 2013.
13. Rapelanoro R, Mortureux P, Couprie B, Maleville J, Taieb A. Neonatal Malassezia furfur pustulosis. Arch Dermatol. 1996;132(2):190-193.
14. Tom WL, Friedlander SF. Acne through the ages: case-based observations through childhood and adolescence. Clin Pediatr. 2008;47(7):639-651.
15. Friedlander SF, Baldwin HE, Mancini AJ, Yan AC, Eichenfield LF. The acne continuum: age based approach to therapy. Semin Cutan Med Surg. 2011;30(3 Suppl):S6-S11.
16. Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131(Suppl 3):S163-S186.
17. Mann MW, Ellis SS, Mallory SB. Infantile acne as the initial sign of an adrenocortical tumor. J Am Acad Dermatol. 2007;56(2 Suppl):S15-S18.
18. Cantatore Francis JL, Glick SA. Childhood acne: evaluation and management. Dermatol Ther. 2006;19(4)202-209.
19. Golub MS, Collman GW, Foster PM, et al. Public health implications of altered puberty timing. Pediatrics. 2008;121(Suppl 3):S218-S230.
20. Toppari J, Juul A. Trends in puberty timing in human and environmental modifiers. Mol Cell Endocrinol. 2010;324(1-2):39-44.
21. Euling SY, Herman-Giddens ME, Lee PA, et al. Examination of US puberty-timing data from 1940 to 1994 for secular trends: Panel findings. Pediatrics. 2008;121(Suppl 3):S172-S191.
22. Lucky AW, Biro FM, Sumbarti LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five year longitudinal study. J Pedatr. 1997;130(1):30-39.
23. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outdomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1-S50.
24. Worret WI, Fluhr JW. Acne therapy with topical benzoyl peroxide, antibiotics, and azelaic acid. J Dtsch Dermatol Ges. 2006;4(4):293-300.
25. Humphrey S. Antibiotic resistance in acne treatment. Skin Therapy Lett. 2012;17(9):1-3.
26. Zaenglein AL. Topical retinoids in the treatment of acne vulgaris. Semin Cutan Med Surg. 2008;27(3):177-182.
27. Kligman AM, Fulton JE, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol. 1969;99(4):469-476.
28. Cunliffe WJ, Danby FW, Dunlap F, Gold MH, Gratton D, Greenspan A. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Eur J Dermatol. 2002;12(4):350-354.
29. Draelos ZD, Carter E, Maloney M, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.
30. Lucky AW, Maloney JM, Roberts J, et al. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. J Drug Dermatol. 2007;6(10):981-987.
31. Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris. Arch Dermatol. 2008;144(12):1564-1570.
32. Esterly NB, Koransky JS, Furey NL, Trevisan M. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol. 1984;120(10):1308-1313.
33. Tsankov N, Broshtilova V, Kazandjieva J. Tetracyclines in dermatology. Clin Dermatol. 2003;21(1):33-39.
34. Webster GF, Graber EM. Antibiotic treatment for acne vulgaris. Semin Cutan Med Surg. 2008;27(3):183-187.
35. Zaenglein AL, Thiboutot DM. Expert committee recommendations for acne management. Pediatrics. 2006;118(3):1189-1199.
36. Del Rosso JQ, Kim G. Optimizing the use of oral antibiotics in acne vulgaris. Dermatol Clin. 2009;27(1):33-42.
37. Shin J, Cheetham TC, Wong L, et al. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol. 2011;65(6):1117-1125.